On Tuesday, Shares of AK Steel Holding Corporation (NYSE:AKS), subtract -7.07% and closed at $4.60 in the last trading session. The last trading range of the stock ranges between $4.59 and $4.93. AK Steel ( NYSE : AKS ) said recently that it plans to release its third quarter 2016 financial results before the opening of trading on the New York Stock Exchange on Tuesday, October 25, 2016.
AK Steel will also provide live listening access on the Internet to its earnings conference call to be held at 11:00 a.m. Eastern Time on October 25, 2016. Access to the webcast will be available from the home page of the company’s website.
Vodafone Group Plc (ADR)(NASDAQ:VOD), jumped 0.38% and closed at $29.30 in the last trading session. The last trading range of the stock ranges between $29.22 and $29.68. The company’s Market capitalization is $78.05 Billion with the total Outstanding Shares of 26.56 Billion. Vodafone Group Plc operates as a telecommunications company worldwide. The company offers voice, messaging, and data services across mobile and fixed networks; broadband and TV services; cloud and hosting, in addition to Internet protocol-virtual private network services; roaming services; and unified communications services. It also provides M-Pesa, a mobile money transfer and payment service; and Vodafone One, an ultra-high-speed fixed broadband service with Ono Fibre, home landline, 4G mobile telephony, and Vodafone TV. In addition, Vodafone Group Plc offers Internet of Things (IoT), which is communication between devices via mobile technologies; international voice transit and roaming; carrier services, such as fixed and mobile connectivity and other services; and smartphones and tablets.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), subtract -5.24% and closed at $29.10 in the last trading session. The last trading range of the stock ranges between $28.40 and $30.93. During the 52-week trading session the minimum price at which share price traded, registered at $16.64 and reached to max level of $43.30. ACADIA Pharmaceuticals Inc. (ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, recently declared that it will present at the Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September 27, 2016, at 9:00 a.m. Eastern Time in New York City.